In addition, some anticancer treatments, for example, treatment of CAL-27 cells with 11-dehydrosinulariolide and A375 melanoma cells with sinulariolide, markedly downregulate UQCRC1 [34, 35]. This evidence concerns the gene UQCRC1 and melanoma.